Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patientsBMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7202.87 (Published 10 July 1999) Cite this as: BMJ 1999;319:87
The members of the Montelukast Study Group were Andre Cartier, Montreal, Canada; Ken Chapman, Toronto, Canada; Thomas B Edwards, Albany, NY, USA; Albert F Finn Jr, North Charleston, SC, USA; J Mark Fitzgerald, Vancouver, Canada; Philippe Godard, Montpellier, France; Tari Haahtela, Helsinki, Finland; Yngve Hornblad, Malmö, Sweden; Elliot Israel, Boston, MA, USA; William Klaustermeyer, Los Angeles, CA, USA; Claes-Goran Löfdahl, Lund, Sweden; Andreas Meyer, Hamburg, Germany; Harold Nelson, Denver, CO, USA; Michael J Noonan, Portland, OR, USA; David S Pearlman, Aurora, CO, USA; Andrew J Pedinoff, Princeton, NJ, USA; Bruce Prenner, San Diego, CA, USA; Leif Rosenhall, Huddinge, Sweden; Anthony Scardella, New Brunswick, NJ, USA; Bengt-Eric Skoogh, Gothenburg, Sweden; A M J Wever, Netherlands; Richard White, Sacramento, CA, USA; James D Wolfe, San Jose, CA, USA.
- Constitutional symptoms in a young personBMJ December 07, 2016, 355 i5781; DOI: https://doi.org/10.1136/bmj.i5781
- An adolescent with disabling abdominal painBMJ December 07, 2016, 355 i6101; DOI: https://doi.org/10.1136/bmj.i6101
- Andrew Wakefield calls Trump “on our side” over vaccines after meetingBMJ December 05, 2016, 355 i6545; DOI: https://doi.org/10.1136/bmj.i6545
- Doctors in Pakistan call for workers deported from the UAE to be screened for HIVBMJ December 05, 2016, 355 i6544; DOI: https://doi.org/10.1136/bmj.i6544
- Communicating risk to patients in the emergency departmentBMJ December 05, 2016, 355 i6437; DOI: https://doi.org/10.1136/bmj.i6437
- Leukotriene receptor antagonist therapy and Churg-Strauss syndrome: culprit or innocent bystander?
- Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review
- Global strategy for asthma management and prevention: GINA executive summary
- Tapering Dose of Inhaled Budesonide in Subjects with Mild-to-Moderate Persistent Asthma Treated with Montelukast: A 16-Week Single-Blind Randomized Study
- Pharmacological Treatment of Airway Remodeling: Inhaled Corticosteroids or Antileukotrienes?
- Journal Watch
- Management of asthma in adults: current therapy and future directions
- Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma
- Leukotriene receptor antagonists as add-on therapy for adults with asthma
- Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
- Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone
- Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
- Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence
- Pharmacological treatment of asthma today
- Leukotriene Modifiers in Pediatric Asthma Management
- Leukotriene receptor antagonist therapy
- Leukotriene receptor antagonists: useful in acute asthma?
- Montelukast Reduces Need for Inhaled Corticosteroids in Asthma